New York Oncology Hematology
In research, New York Oncology Hematology stands highest in Medicine (#12,727 of 17,978 worldwide) and Health Sciences (#15,711 of 20,462 worldwide), over all time.
- World rank, all time
- #27,881 of 42,892
- Rank in United States
- #5,982 of 8,685
- Research works
- 191 ▲ 30% vs 2013–17
- Citations
- 6.1k 31.8 per fractional work
- Top-10% rate
- 8.7% record average 16.5%
- Open access
- 35% world 28%
What is New York Oncology Hematology known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #12,727 of 17,978 | 17.3% | 130 | |
| Health SciencesDomain | #15,711 of 20,462 | 17.2% | 135 |
Each strip is that field’s whole ranked pool, with the notch where New York Oncology Hematology sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.6×. Every wedge is a field page.
- Medicine 3.6×
- Biochemistry, Genetics and Molecular Biology 3.1×
- Immunology and Microbiology 2.6×
- Neuroscience 1.3×
- Dentistry 1.0×
- Economics, Econometrics and Finance 0.8×
- Nursing 0.4×
- Agricultural and Biological Sciences 0.4×
- Health Professions 0.3×
- Physics and Astronomy 0.2×
- Mathematics 0.2×
- Business, Management and Accounting 0.2×
- Engineering 0.1×
- Social Sciences 0.1×
- Computer Science 0.0×
- Environmental Science 0.0×
Which keywords describe research at New York Oncology Hematology?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Prognostic Factors, Targeted Therapy, Radiotherapy, Epidemiology, Immunotherapy, Clinical Trials and Genetic Mutations.
- Pathogenesis
- Management
- Gene Expression Profiling
- Breast Cancer
- Tumor Microenvironment
- Thalassemia
- Precision Medicine
- Minimal Residual Disease
- Clinical Practice Guidelines
- Quality of Life
- Diagnosis
- Cancer
- Immunotherapy
- Targeted Therapy
- Epidemiology
- Chemotherapy
- Prognostic Factors
- Radiotherapy
- Clinical Trials
- Genetic Mutations
- Genomic Profiling
- Rituximab
- Genomic Instability
- PET Imaging
- Sickle-cell Disease
- Treatment Guidelines
- ALK Inhibitors
- EGFR Mutations
- Inflammation
- Molecular Profiling
- Treatment
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 31 words, with their numbers
- Chemotherapy4▲ 16×12 topics
- Epidemiology4▲ 2.7×24 topics
- Prognostic Factors3▲ 19×11 topics
- Targeted Therapy3▲ 35×4 topics
- Radiotherapy2▲ 19×8 topics
- Immunotherapy2▲ 9.1×10 topics
- Clinical Trials2▲ 8.5×5 topics
- Cancer2▲ 4.1×12 topics
- Genetic Mutations2▲ 11×10 topics
- Diagnosis1▲ 4.5×13 topics
- Genomic Profiling1▲ 41×2 topics
- Quality of Life1▲ 3.0×11 topics
- Rituximab1▲ 26×2 topics
- Clinical Practice Guidelines1▲ 6.4×6 topics
- Genomic Instability1▲ 32×3 topics
- Minimal Residual Disease1▲ 51×2 topics
- PET Imaging1▲ 21×4 topics
- Precision Medicine1▲ 7.4×4 topics
- Sickle-cell Disease1▲ 84×1 topic
- Thalassemia1▲ 84×1 topic
- Treatment Guidelines1▲ 17×2 topics
- Tumor Microenvironment1▲ 8.1×5 topics
- ALK Inhibitors1▲ 55×1 topic
- Breast Cancer1▲ 13×4 topics
- EGFR Mutations1▲ 55×1 topic
- Gene Expression Profiling1▲ 40×2 topics
- Inflammation1▲ 1.53×9 topics
- Management1▲ 4.1×8 topics
- Molecular Profiling1▲ 33×2 topics
- Pathogenesis1▲ 6.2×7 topics
- Treatment1▲ 2.6×10 topics
Which research topics does New York Oncology Hematology publish most on?
By volume in 2022–2025: Hemoglobinopathies and Related Disorders, Lung Cancer Treatments and Mutations, Multiple Myeloma Research and Treatments and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemoglobinopathies and Related Disorders Genetics 1 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 3 Multiple Myeloma Research and Treatments Hematology 1 works
- 4 Cancer Genomics and Diagnostics Cancer Research 1 works
- 5 Barrier Structure and Function Studies Neurology 1 works
- 6 Head and Neck Cancer Studies Otorhinolaryngology 1 works
- 7 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 9 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 10 Radiation Effects and Dosimetry Food Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has New York Oncology Hematology's research output changed?
Output in 2018–2022 was 30% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in New York
- Columbia University
- New York University
- Icahn School of Medicine at Mount Sinai
- Memorial Sloan Kettering Cancer Center
- City University of New York
- Human Growth Foundation
- Columbia University Irving Medical Center
- Rockefeller University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.